Guideline linked to reduction in urodynamics testingResearchers have reported an association with the release of the AUA/SUFU Adult Urodynamics Guideline and reduction of urodynamics performed for diagnosis of overactive bladder, stress urinary incontinence, and mixed urinary incontinence.
General urologists less likely to utilize third-line OAB treatmentsGeneral urologists are less likely to utilize third-line interventions for overactive bladder than those with additional female pelvic medicine and reconstructive surgery training.
Guideline-based medicine: A take-away from the AUA oral board examHenry Rosevear, MD, reflects on his recent experience as a faculty member at the AUA oral board exam.
Congressional retirements promise to make waves"No matter the most accurate interpretation of the current spate of retirements, the volume of vacancies promises to alter the political calculus in Washington," writes the AACU's Brian Henderson.
Why your practice should consider team-based care"In the team-based care approach, every member of the care team should work to the highest level of their training and skill set," writes new Urology Times blogger Rick Rutherford, CMPE.
Quality of stone care: We can do betterA recent study "revealed that inadequate pain control, presence of a ureteral stent, and a first-time stone treatment were the most common reasons for unplanned utilization of health care services [following ureteroscopy]," writes Brian R. Matlaga, MD, MPH.
Unplanned encounters common after ureteroscopyFindings of a retrospective study confirm that unplanned encounters are common after ureteroscopy.
[Quiz]: Abnormality seen in post-PCNL imagingA 42-year-old female undergoes right percutaneous nephrolithotomy (PCNL) for a complete staghorn calculus. As a routine after PCNL, a chest-x-ray was obtained using fluoroscopy. What abnormality is seen?
New Products: BPH surgical robot granted FDA de novo requestOther products highlighted in this round-up include a plate for studying infections caused by the long-term use of catheters and a new indication for sunitinib malate (SUTENT).
Uro Pipeline: FDA accepts priority review application for RCC treatmentAgents for bladder cancer, prostate cancer, and stress urinary incontinence are also included in this round-up of pipeline developments.